Tumor lysis syndrome (TLS) is an oncologic emergency characterized by life-threatening metabolic disturbances. Although it is most frequently associated with the treatment of hematological malignancies, its frequency may be increasing among patients with solid tumors. Emergency providers should be familiar with the presentation and treatment of these electrolyte abnormalities, which can lead to renal failure, seizures, and cardiac dysrhythmias. ALiEM Cards: Tumor Lysis Syndrome, written by Drs. Christopher Nash and Derek Monette, reviews TLS and the latest updates in its management.
About ALiEM Cards
ALiEM Cards is point-of-care reference library with narrowly focused, easily digestible cards for the practicing emergency physician or learner (formerly known as PV Cards).
Please let us know how you use these cards, what would make them more useful, or if you would like to suggest a topic.
Author information
ALiEM Cards Lead Developer
2015-16 ALiEM-AgileMD Design Fellow
Attending Physician
St. Mark's Hospital
Salt Lake City, UT
The post ALiEM Cards: Tumor Lysis Syndrome appeared first on ALiEM.
